These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 34983540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. B-Cell Epitope Mapping of the Plasmodium falciparum Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon.
    Baptista BO, Souza ABL, Oliveira LS, Souza HADS, Barros JP, Queiroz LT, Souza RM, Amoah LE, Singh SK, Theisen M, Rodrigues-da-Silva RN, Riccio EKP, Totino PRR, Lima-Junior JDC, Daniel-Ribeiro CT, Pratt-Riccio LR.
    Vaccines (Basel); 2023 Feb 15; 11(2):. PubMed ID: 36851323
    [Abstract] [Full Text] [Related]

  • 3. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
    Mamo H, Esen M, Ajua A, Theisen M, Mordmüller B, Petros B.
    Malar J; 2013 Feb 05; 12():51. PubMed ID: 23383869
    [Abstract] [Full Text] [Related]

  • 4. Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens.
    Amoani B, Gyan B, Sakyi SA, Abu EK, Nuvor SV, Barnes P, Sarkodie-Addo T, Ahenkorah B, Sewor C, Dwomoh D, Theisen M, Cappello M, Wilson MD, Adu B.
    BMC Infect Dis; 2021 Apr 08; 21(1):332. PubMed ID: 33832450
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen.
    Baldwin SL, Roeffen W, Singh SK, Tiendrebeogo RW, Christiansen M, Beebe E, Carter D, Fox CB, Howard RF, Reed SG, Sauerwein R, Theisen M.
    Vaccine; 2016 Apr 27; 34(19):2207-15. PubMed ID: 26994314
    [Abstract] [Full Text] [Related]

  • 9. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE, Nuvor SV, Obboh EK, Acquah FK, Asare K, Singh SK, Boampong JN, Theisen M, Williamson KC.
    Parasit Vectors; 2017 Aug 23; 10(1):395. PubMed ID: 28835262
    [Abstract] [Full Text] [Related]

  • 10. A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.
    Alkema M, Smit MJ, Marin-Mogollon C, Totté K, Teelen K, van Gemert GJ, van de Vegte-Bolmer M, Mordmüller BG, Reimer JM, Lövgren-Bengtsson KL, Sauerwein RW, Bousema T, Plieskatt J, Theisen M, Jore MM, McCall MBB.
    BMC Med; 2024 Apr 23; 22(1):170. PubMed ID: 38649867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The GMZ2 malaria vaccine: from concept to efficacy in humans.
    Theisen M, Adu B, Mordmüller B, Singh S.
    Expert Rev Vaccines; 2017 Sep 23; 16(9):907-917. PubMed ID: 28699823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children.
    Bélard S, Issifou S, Hounkpatin AB, Schaumburg F, Ngoa UA, Esen M, Fendel R, de Salazar PM, Mürbeth RE, Milligan P, Imbault N, Imoukhuede EB, Theisen M, Jepsen S, Noor RA, Okech B, Kremsner PG, Mordmüller B.
    PLoS One; 2011 Sep 23; 6(7):e22525. PubMed ID: 21829466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody Responses Against Plasmodium vivax TRAP Recombinant and Synthetic Antigens in Naturally Exposed Individuals From the Brazilian Amazon.
    Matos ADS, Rodrigues-da-Silva RN, Soares IF, Baptista BO, de Souza RM, Bitencourt-Chaves L, Totino PRR, Sánchez-Arcila JC, Daniel-Ribeiro CT, López-Camacho C, Reyes-Sandoval A, Pratt-Riccio LR, Lima-Junior JDC.
    Front Immunol; 2019 Sep 23; 10():2230. PubMed ID: 31620136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.